FDA to Reassess Safety Risk for Avandia

The onetime blockbuster diabetes drug Avandia is getting an unusual safety reassessment by federal regulators three years after they curbed its sales over cardiovascular risks.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news